These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
906 related items for PubMed ID: 16938649
1. Different viral kinetics between hepatitis C virus genotype 1 and 2 as on-treatment predictors of response to a 24-week course of high-dose interferon-alpha plus ribavirin combination therapy. Yu ML, Chuang WL, Dai CY, Lee LP, Hsieh MY, Lin ZY, Chen SC, Hsieh MY, Wang LY, Chang WY, Tsai SL, Kuo HT. Transl Res; 2006 Sep; 148(3):120-7. PubMed ID: 16938649 [Abstract] [Full Text] [Related]
2. Hepatitis C virus-RNA clearance in HIV-coinfected patients with chronic hepatitis C treated with pegylated interferon plus ribavirin. Soriano V, Núñez M, Camino N, Maida I, Barreiro P, Romero M, Martin-Carbonero L, Garcia-Samaniego J, González-Lahoz J. Antivir Ther; 2004 Aug; 9(4):505-9. PubMed ID: 15456081 [Abstract] [Full Text] [Related]
5. Predictive factors of virological non-response to interferon-ribavirin combination therapy for patients infected with hepatitis C virus of genotype 1b and high viral load. Akuta N, Suzuki F, Sezaki H, Suzuki Y, Hosaka T, Someya T, Kobayashi M, Saitoh S, Watahiki S, Sato J, Kobayashi M, Arase Y, Ikeda K, Kumada H. J Med Virol; 2006 Jan; 78(1):83-90. PubMed ID: 16299715 [Abstract] [Full Text] [Related]
11. Alpha-interferon with ribavirin in the treatment of hemodialysis patients with hepatitis C. Mousa DH, Abdalla AH, Al-Shoail G, Al-Sulaiman MH, Al-Hawas FA, Al-Khader AA. Transplant Proc; 2004 Jan; 36(6):1831-4. PubMed ID: 15350490 [Abstract] [Full Text] [Related]
12. Antiviral therapy for recurrent hepatitis C after liver transplantation: sustained virologic response is related to genotype 2/3 and response at week 12. Raziorrouh B, Jung MC, Schirren CA, Loehe F, Thiel M, Nitschko H, Diepolder H, Ulsenheimer A, Heeg M, Zachoval R, Gruener NH. Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):778-83. PubMed ID: 18617783 [Abstract] [Full Text] [Related]
13. [Early prediction of lack of response to treatment with interferon and interferon plus ribavirin using biochemical and virological criteria in patients with chronic hepatitis C]. Olaso V, Córdoba J, Lòpez Viedma B, Siles MS, Molina JM, Prieto M, Baum I, Gobernado M, Berenguer J. Rev Esp Quimioter; 1999 Sep; 12(3):220-8. PubMed ID: 10878512 [Abstract] [Full Text] [Related]